Cargando…
Biogenic synthesis of ZnO and Al(2)O(3) nanoparticles using Camellia sinensis and Origanum vulgare L. leaves extract for spectroscopic estimation of ofloxacin and ciprofloxacin in commercial formulations
The current study describes the biogenic synthesis of two metal oxides zinc oxide (ZnO), aluminum oxide (Al(2)O(3)) nanoparticles using Camellia sinensis, and Origanum vulgare L. leaves extract, respectively. The synthesized metal oxide nanoparticles were investigated using spectroscopic and microsc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617719/ https://www.ncbi.nlm.nih.gov/pubmed/37906583 http://dx.doi.org/10.1371/journal.pone.0286341 |
Sumario: | The current study describes the biogenic synthesis of two metal oxides zinc oxide (ZnO), aluminum oxide (Al(2)O(3)) nanoparticles using Camellia sinensis, and Origanum vulgare L. leaves extract, respectively. The synthesized metal oxide nanoparticles were investigated using spectroscopic and microscopic techniques to confirm the formation of their nanostructures. Accurate and precise spectrofluorometric probes were proposed for the quantification of Ofloxacin (OFX) and Ciprofloxacin (CPFX) in their bulk and commercial formulations. The extraordinary properties of Zinc oxide and aluminum oxide nanoparticles (ZnONPs and Al(2)O(3)NPs) enhance the fluorescence intensity in the presence of 0.5 mL and 1.0 mL of sodium dodecyl sulfate (SDS, 1.0% w/v) as organizing agent for the detection of OFX and CPFX, respectively. The optical detection of both drugs at λ(ex/em) range 250–700 nm displayed linearity with a main correlation coefficient >0.999 at 1–300 (OFX-SDS-ZnONPs) and 0.5–100 (OFX-SDS-Al(2)O(3)NPs) ng mL(-1),10–400 (CPFX-SDS-ZnONPs) and 0.1–50 (CPFX-SDS-Al(2)O(3)NPs) ng mL(-1). The detection and quantification limits were found to be 0.04, 0.03, and 0.02, 0.04 ng mL(-1), 0.13, 0.10, and 7.24, 0.09 ng mL(-1) for the above-mentioned fluorescence systems, respectively. The suggested spectrofluorometric probes were validated and potentially applied for the estimation of OFX and CPFX in their bulk and commercial formulations. |
---|